Is Biofrontera Stock a good buy in 2023, according to Wall Street analysts?
The consensus among 2 Wall Street analysts covering (NASDAQ: BFRI) stock is to Strong Buy BFRI stock.
Out of 2 analysts, 2 (100%) are recommending BFRI as a Strong Buy, 0 (0%) are recommending BFRI as a Buy, 0 (0%) are recommending BFRI as a Hold, 0 (0%) are recommending BFRI as a Sell, and 0 (0%) are recommending BFRI as a Strong Sell.
What is BFRI's forecast return on equity (ROE) for 2023-2026?
(NASDAQ: BFRI) forecast ROE is N/A, which is considered weak.
What is BFRI's Price Target?
According to 2 Wall Street analysts that have issued a 1 year BFRI price target, the average BFRI price target is $7.00, with the highest BFRI stock price forecast at $7.00 and the lowest BFRI stock price forecast at $7.00.
On average, Wall Street analysts predict that Biofrontera's share price could reach $7.00 by May 15, 2024. The average Biofrontera stock price prediction forecasts a potential upside of 1,361.38% from the current BFRI share price of $0.48.
What is BFRI's forecast return on assets (ROA) for 2023-2026?
(NASDAQ: BFRI) forecast ROA is N/A, which is lower than the forecast US Drug Manufacturers - Specialty & Generic industry average of 0.03%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.